DE60118893D1 - Inulin produkte mit verbesserten nahrungseigenschaften - Google Patents

Inulin produkte mit verbesserten nahrungseigenschaften

Info

Publication number
DE60118893D1
DE60118893D1 DE60118893T DE60118893T DE60118893D1 DE 60118893 D1 DE60118893 D1 DE 60118893D1 DE 60118893 T DE60118893 T DE 60118893T DE 60118893 T DE60118893 T DE 60118893T DE 60118893 D1 DE60118893 D1 DE 60118893D1
Authority
DE
Germany
Prior art keywords
inulin
humans
manufacture
products
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60118893T
Other languages
English (en)
Other versions
DE60118893T2 (de
Inventor
Anne Frippiat
Loo Jan Van
Georges Smits
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tiense Suikerraffinaderij NV
Original Assignee
Tiense Suikerraffinaderij NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8167853&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60118893(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tiense Suikerraffinaderij NV filed Critical Tiense Suikerraffinaderij NV
Publication of DE60118893D1 publication Critical patent/DE60118893D1/de
Application granted granted Critical
Publication of DE60118893T2 publication Critical patent/DE60118893T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733Fructosans, e.g. inulin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/244Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/18Reserve carbohydrates, e.g. glycogen, inulin, laminarin; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicinal Preparation (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Seeds, Soups, And Other Foods (AREA)
DE60118893T 2000-02-15 2001-02-14 Insulinprodukte mit verbesserten nahrungseigenschaften Expired - Lifetime DE60118893T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00103056 2000-02-15
EP00103056A EP1125507A1 (de) 2000-02-15 2000-02-15 Inulinprodukte mit verbesserten Nahrungseigenschaften
PCT/EP2001/001600 WO2001060176A1 (en) 2000-02-15 2001-02-14 Inulin products with improved nutritional properties

Publications (2)

Publication Number Publication Date
DE60118893D1 true DE60118893D1 (de) 2006-05-24
DE60118893T2 DE60118893T2 (de) 2006-11-16

Family

ID=8167853

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60118893T Expired - Lifetime DE60118893T2 (de) 2000-02-15 2001-02-14 Insulinprodukte mit verbesserten nahrungseigenschaften

Country Status (14)

Country Link
US (3) US7812004B2 (de)
EP (2) EP1125507A1 (de)
JP (2) JP5270058B2 (de)
KR (1) KR100516532B1 (de)
CN (1) CN1221182C (de)
AT (1) ATE323425T1 (de)
AU (2) AU4239201A (de)
BR (1) BR0108341B1 (de)
CA (1) CA2395623C (de)
DE (1) DE60118893T2 (de)
DK (1) DK1259125T3 (de)
ES (1) ES2258076T3 (de)
MX (1) MXPA02007689A (de)
WO (1) WO2001060176A1 (de)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2179726A3 (de) 1995-12-26 2012-09-26 Block Drug Company, Inc. Ballaststoff-Inulinbereitstellungssystem
EP1125507A1 (de) * 2000-02-15 2001-08-22 Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.) Inulinprodukte mit verbesserten Nahrungseigenschaften
US8187624B1 (en) 2000-06-14 2012-05-29 Kao Corporation Compositions for taking dietary fibers
EP1174118A1 (de) * 2000-06-28 2002-01-23 Cognis France S.A. Verwendung von Inulinen und Inulinderivaten
EP1243273A1 (de) 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Zubereitung enthaltend einen praebiotischen Stoff für die Behandlung von Entzündungen und abnormale Aktivierung von nicht-spezifischen immunologischen Parametern
US20040001898A1 (en) * 2002-06-26 2004-01-01 Armand Malnoe Compositions and methods for detoxification and cancer prevention
WO2004002240A2 (en) * 2002-06-26 2004-01-08 Danisco A/S Use of hydrocolloids as prebiotic food ingredients and method of producing the same
EP1428528A1 (de) * 2002-09-27 2004-06-16 Tiense Suikerraffinaderij N.V. Synergistische Zusammensetzungen aus Ballaststoffe und NSAID zur Behandlung von Krebs
FR2848783B1 (fr) * 2002-12-18 2005-05-13 Agronomique Inst Nat Rech Utilisation de prebiotiques pour prevenir ou traiter le stress oxydant
JP2005104938A (ja) * 2003-10-02 2005-04-21 Matsukawa Kagaku:Kk 皮膚用化粧料
JP2005124432A (ja) * 2003-10-22 2005-05-19 Shuichi Shiomi 健康食品
US20050119222A1 (en) 2003-12-01 2005-06-02 The Iams Company Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use
US20050118234A1 (en) * 2003-12-01 2005-06-02 The Iams Company Methods and kits related to administration of a fructooligosaccharide
EP1817964A1 (de) * 2006-02-13 2007-08-15 Sweetwell NV Funktioneller Zuckerersatz
US20070082104A1 (en) * 2004-08-12 2007-04-12 Sophie De Baets Functional sugar replacement
US20060051480A1 (en) * 2004-09-03 2006-03-09 Loren Miles Sweetener composition
US20080213452A1 (en) * 2004-09-03 2008-09-04 Loren Miles All natural sweetener compositions
US8956677B2 (en) * 2005-11-23 2015-02-17 The Coca-Cola Company High-potency sweetener composition with glucosamine and compositions sweetened therewith
US20070134391A1 (en) * 2005-11-23 2007-06-14 The Coca-Cola Company High-Potency Sweetener Composition for Treatment and/or Prevention of Autoimmune Disorders and Compositions Sweetened Therewith
US9144251B2 (en) * 2005-11-23 2015-09-29 The Coca-Cola Company High-potency sweetener composition with mineral and compositions sweetened therewith
US20070116836A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company High-Potency Sweetener Composition for Treatment and/or Prevention of Osteoporosis and Compositions Sweetened Therewith
CA2629556A1 (en) * 2005-11-23 2007-07-19 The Coca Cola Company Synthetic sweetener compositions with improved temporal profile and/or flavor profile, methods for their formulation, and uses
US8956678B2 (en) * 2005-11-23 2015-02-17 The Coca-Cola Company High-potency sweetener composition with preservative and compositions sweetened therewith
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
US8993027B2 (en) * 2005-11-23 2015-03-31 The Coca-Cola Company Natural high-potency tabletop sweetener compositions with improved temporal and/or flavor profile, methods for their formulation, and uses
US20070116831A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company Dental Composition with High-Potency Sweetener
US20070116825A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company Confection with High-Potency Sweetener
US20070116822A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company High-potency sweetener composition with saponin and compositions sweetened therewith
GB0524128D0 (en) * 2005-11-28 2006-01-04 Barry Callebaut Ag Compositions
US20070224323A1 (en) * 2006-03-23 2007-09-27 Fred Goldman Sugar Replacement and Baked Goods and Caramels Using the Sugar Replacement
US20070269569A1 (en) * 2006-05-22 2007-11-22 Bashor Michael P Reduced-calorie icing compositions comprising inulin
JPWO2007142306A1 (ja) * 2006-06-08 2009-10-29 株式会社アガベ 高水溶性アガベ・イヌリン、アガベ・イヌリン含有製品、アガベ・イヌリン由来製品、副産物及びそれらの製法
US20080171124A1 (en) * 2006-10-03 2008-07-17 Loren Miles All natural sweetener composition
US20080102166A1 (en) * 2006-10-26 2008-05-01 Cargill, Incorporated Fiber-Containing Confectionary Chews
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
US20080107787A1 (en) * 2006-11-02 2008-05-08 The Coca-Cola Company Anti-Diabetic Composition with High-Potency Sweetener
US9101161B2 (en) * 2006-11-02 2015-08-11 The Coca-Cola Company High-potency sweetener composition with phytoestrogen and compositions sweetened therewith
US20080113075A1 (en) * 2006-11-09 2008-05-15 Barry Callebaut Ag Compositions
EP2129240A4 (de) * 2007-02-23 2010-03-17 Miles Loren Zu hundert prozent natürliche süssstoffzusammensetzung
US20080299258A1 (en) * 2007-04-18 2008-12-04 Roman Stephen B Probiotic natural sweetener compositions with standardized levels of fiber and process to make
US20090148580A1 (en) * 2007-12-06 2009-06-11 Heyer Juan A Use of natural agave extract as a natural sweetener replacing other added sweeteners in food products and medicines
US8828953B2 (en) * 2009-04-20 2014-09-09 NaZura BioHealth, Inc. Chemosensory receptor ligand-based therapies
US9901551B2 (en) 2009-04-20 2018-02-27 Ambra Bioscience Llc Chemosensory receptor ligand-based therapies
GB0907019D0 (en) * 2009-04-24 2009-06-03 Oxford Nutrascience Ltd Pharmaceutical,therapeutic or nutritional delivery systems for functional ingredients
ITMI20091566A1 (it) * 2009-09-14 2011-03-14 Nyelis S R L Composizioni farmaceutiche,medicali,nutraceutiche e dietetiche aventi lo scopo di massimizzare la bioaccessibilita' e la biodisponibilita' del magnesio
US10334870B2 (en) 2010-10-07 2019-07-02 Tropicana Products, Inc. Processing of whole fruits and vegetables, processing of side-stream ingredients of fruits and vegetables, and use of the processed fruits and vegetables in beverage and food products
KR20140114736A (ko) 2010-10-19 2014-09-29 엘셀릭스 테라퓨틱스 인코포레이티드 화학감각 수용체 리간드-기반 요법
WO2012066485A2 (en) * 2010-11-19 2012-05-24 Centro De Investigación Y De Estudios Avanzados Del Instituto Politécnico Nacional Agave fructans compositions and their use in mineral absorption
US20120135109A1 (en) * 2010-11-30 2012-05-31 Tropicana Products, Inc. Fiber obtained from fruit or vegetable byproducts
WO2012155220A1 (en) 2011-05-13 2012-11-22 Danone Ltda. Composition comprising a mixture of fibers
AR087157A1 (es) 2011-06-20 2014-02-26 Gen Biscuit Galletita saludable
RU2481815C1 (ru) * 2011-12-06 2013-05-20 Государственное бюджетное учреждение здравоохранения "Самарский областной гериатрический центр" Способ увеличения минеральной плотности костной ткани
CN103100006A (zh) * 2013-01-30 2013-05-15 无限极(中国)有限公司 一种具有降尿酸功能的中草药组合物
RU2605352C1 (ru) 2013-02-15 2016-12-20 Пепсико, Инк. Получение и включение побочных продуктов в напитки для повышения питательной ценности и улучшения органолептических свойств
WO2014161666A1 (en) 2013-04-05 2014-10-09 Beneo-Orafti S.A. Alcoholic liquid formulation comprising partially crystalline fructan
ES2725631T3 (es) * 2013-08-01 2019-09-25 Anatoly Derin Método para el suministro de sustancias que promueven la salud en el cuerpo humano
WO2017021413A1 (en) * 2015-08-04 2017-02-09 Südzucker AG Prophylactic use of inulin against sinusitis
EP3349790A1 (de) * 2015-09-18 2018-07-25 Rijksuniversiteit Groningen Langkettiges inulin zur stimulierung einer immunantwort
US11297867B2 (en) * 2016-07-26 2022-04-12 PT. Lautan Natural Krimerindo Functional food and their manufacturing process as well as the application on food and beverage products
CN109380635A (zh) * 2017-08-10 2019-02-26 赵同利 一种菊粉水苏糖固体饮料
US20210076720A1 (en) * 2018-02-23 2021-03-18 Firmenich Sa Shelf stable powdered composition
KR102082315B1 (ko) * 2018-05-08 2020-02-27 주식회사 비피도 부티릴 프락토올리고당을 포함하는 프리바이오틱스 조성물
US10806169B2 (en) * 2018-05-15 2020-10-20 Kate Farms, Inc. Hydrolyzed pea protein-based nutrient composition
CN109315728A (zh) * 2018-09-19 2019-02-12 北京爱仁医疗科技有限公司 一种含有虾青素的食品及其在肠道菌群调节中的应用
JP7321503B2 (ja) * 2019-05-21 2023-08-07 フジ日本精糖株式会社 イヌリンを含む筋肉量減少抑制又は骨密度減少抑制剤
CN113287758A (zh) * 2021-02-22 2021-08-24 良品铺子营养食品有限责任公司 一种多重复配膳食纤维及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1005438A4 (fr) * 1991-10-04 1993-07-27 Raffinerie Tirlemontoise Sa Compositions de cremes contenant du fructane, procede de preparation de ces compositions et leur utilisation.
JPH07500485A (ja) * 1991-08-07 1995-01-19 ラフィネリイ チアルモントワーゼ ソシエテ アノ ニム 低カロリーチョコレート菓子組成物
WO1996001849A1 (en) * 1994-07-07 1996-01-25 Tiense Suikerraffinaderij Naamloze Vennootschap Fractionated polydisperse compositions
SE9402490D0 (sv) * 1994-07-15 1994-07-15 Jan Ingmar Flock Vitronection binding protein
WO1996003888A1 (en) * 1994-08-01 1996-02-15 Unilever N.V. Water continuous edible spread
EP0756828B2 (de) * 1995-08-04 2010-09-22 N.V. Nutricia Diätfasern enthaltende Nahrungszusammensetzung
BE1010449A3 (fr) * 1996-08-01 1998-08-04 Raffinerie Tirlemontoise Sa Procede de preparation d'une composition polydipersee de saccharides, composition polydispersee de saccharides, produit alimentaire, pharmaceutique et/ou cosmetique comprenant ladite composition polydispersee.
EP0879600A1 (de) 1997-05-20 1998-11-25 Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.) Fruktan-haltige Zusammensetzung zur Vorbeugung und Behandlung von Dickdarmkrebs
US6051260A (en) * 1998-04-07 2000-04-18 Healthcomm International, Inc. Medical food composition of reduced allergenicity, especially adapted for improving gut mucosal integrity
EP0958825A1 (de) 1998-05-18 1999-11-24 Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.) Synergistische Zusammensetzung zur Behandlung von Krebs, welche unverdauliche Kohlenhydrate und eines Antikrebsmittel enthält
DK1010374T3 (da) * 1998-12-15 2005-11-21 Nestle Sa Fiberblanding til enterale sammensætninger
EP1125507A1 (de) * 2000-02-15 2001-08-22 Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.) Inulinprodukte mit verbesserten Nahrungseigenschaften

Also Published As

Publication number Publication date
KR20020076311A (ko) 2002-10-09
BR0108341A (pt) 2003-03-18
WO2001060176A1 (en) 2001-08-23
AU4239201A (en) 2001-08-27
US10335430B2 (en) 2019-07-02
JP2003522822A (ja) 2003-07-29
AU2001242392B2 (en) 2005-02-10
ES2258076T3 (es) 2006-08-16
US20100261671A1 (en) 2010-10-14
US20030068429A1 (en) 2003-04-10
CA2395623A1 (en) 2001-08-23
BR0108341B1 (pt) 2013-12-03
CN1221182C (zh) 2005-10-05
JP5270058B2 (ja) 2013-08-21
DK1259125T3 (da) 2006-09-04
US20070042992A1 (en) 2007-02-22
JP2010120945A (ja) 2010-06-03
US7812004B2 (en) 2010-10-12
CN1400869A (zh) 2003-03-05
MXPA02007689A (es) 2002-12-13
KR100516532B1 (ko) 2005-09-22
EP1125507A1 (de) 2001-08-22
EP1259125B1 (de) 2006-04-19
EP1259125A1 (de) 2002-11-27
DE60118893T2 (de) 2006-11-16
CA2395623C (en) 2006-08-01
ATE323425T1 (de) 2006-05-15

Similar Documents

Publication Publication Date Title
DE60118893D1 (de) Inulin produkte mit verbesserten nahrungseigenschaften
BR0011234A (pt) Composições de glicomanana e métodos para reduzir a viscosidade de composições de glicomanana
IL162590A0 (en) Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis
BR0214838A (pt) Composição para promoção de crescimento ósseo e manutenção da saúde óssea
SE8702180D0 (sv) Multivitaminkomposition
AR067906A1 (es) Lactobacillus rhamnosus y control del peso
MX211559B (en) A method to prepare food seasoning, food ingredient and food item compositions, seasoning and use thereof
DK0961552T3 (da) Næringstilskud til pædiatriske patienter
IT1274734B (it) Composizioni farmaceutiche contenenti acidi grassi poliinsaturi, loro esteri o sali, unitamente a vitamine o provitamine antiossidanti
BR0211888A (pt) Materiais e métodos para promoção de reparo de tecido nervoso
IL117773A (en) Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability
EP0798001A3 (de) Kollagen-enthaltende Zubereitungen zur Verstärkung des Knochens
PL318498A1 (en) Floor lining
PT831882E (pt) Composicoes de segmentos de fibra de colagenio reconstituido e metodos de preparacao das mesmas
BR9810121A (pt) Utilização do acido petroselìnico nativo ou esterificado
WO2002043659A3 (en) Composition containing statins and calcium for improved cardiovascular health
MXPA04005993A (es) Producto alimenticio que contiene capsulas o tabletas de gel.
MXPA03007024A (es) Enlace de endotoxina por bacteria y bifidobacteria de acido lactico.
MX2015005649A (es) Hidrolizado de colageno y uso del mismo.
NZ333724A (en) Enhancing lean tissue mass and bone mineral content by the administration of calcium compositions
HK1027751A1 (en) Pharmaceutical compositions containing vitamin D and calcium, their preparation and therapeutic use.
BR9813130A (pt) Lanches de baixa gordura e composições de massa compreendendo uma mistura de monoglicerìdio/poliglicerol éster/lipìdio
IT1241028B (it) Prodotti di carne a basso contenuto calorico e procedimento per la loro produzione
EP0481240A3 (en) Galactomannan derivate for the encapsulation or incorporation of drugs
BG103728A (en) Derivatives of dolastatin-15 in combination with taxanes

Legal Events

Date Code Title Description
8363 Opposition against the patent